<DOC>
	<DOCNO>NCT02991417</DOCNO>
	<brief_summary>This clinical study conduct assess safety immunogenicity Clostridium difficile vaccine ( CDVAX ) healthy adult volunteer .</brief_summary>
	<brief_title>Oral Vaccination Against Clostridium Difficile Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<criteria>1 . Written inform consent 2 . Male 3 . Age : 1850 year ( limit include ) 4 . Body mass index within 18.5 29.9 kg/mÂ² 5 . Ability read comprehend study information 6 . Nonsmokers light smoker ( &lt; 4 cigarette per day ) 7 . In good physical mental health determine follow : 1 . Complete medical history 2 . Complete physical neurological examination 3 . Vital sign include blood pressure , heart rate , respiratory rate , temperature 4 . Standard 12lead ECG 5 . Clinical laboratory ( biochemistry , haematology urinalysis ) test . Blood urine sample may draw 3 week prior baseline visit study provide data available evaluate prior administration study drug . Values laboratory result outside normal reference range may acceptable investigator considers compromise safety subject conduct study . 6 . Vital sign , clinical laboratory measurement , ECG measurement may repeat discretion investigator 1 . Evidence C. difficile infection 2 . AntiC . difficile ( Toxin A ) immunoreactivity , suggest previous C. difficile exposure 3 . Diarrhoea , active inactive inflammatory bowel disease , irritable colon syndrome , chronic abdominal pain chronic diarrhoea 4 . History malignancy within 5 year 5 . History anaphylaxis , asthma severe vaccine allergic drug reaction 6 . Known suspected history immunodeficiency , active inactive immunemediated inflammatory disease 7 . Receipt antibiotic therapy , immunosuppressant , corticosteroid within previous 30 day 8 . Vaccination within previous 30 day ( except influenza vaccination ) 9 . Blood organ donation within previous 60 day 10 . Evidence clinically significant psychiatric , gastrointestinal , neurologic , neuromuscular , hepatic , pulmonary , cardiovascular , renal disease ( judged investigator ) 11 . Use prescription medication regular use overthecounter medicine herbal dietary supplement . Acetaminophen/paracetamol may use intermittently need pain 12 . History current evidence abuse drug substance , licit illicit , include alcohol ; positive urine screen drug abuse 13 . Positive hepatitis C antibody ( HCV ) , hepatitis B surface antigen ( HBsAg ) positive human immunodeficiency virus ( HIV ) 1/2 antibody 14 . Participation investigational drug device study within 60 day prior first study drug administration 15 . Relatives , staff directly report principal investigator 16 . Vulnerable subject</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>